Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by firesIayer96on Oct 01, 2012 7:53pm
254 Views
Post# 20435527

RE: New Home for an AURA

RE: New Home for an AURA

Good find es.

Slowly but surely the pieces of the puzzle are being put into place. I understand that Clarion was involved in the selection of some of the beta testing sites (Calgary, Edmonton, now Oakville). Clarion wanted these sites for several reasons, but I think the main ones are because these derms will publicly embrace the Aura and champion its use, through FB, Twitter, Youtube channels, radio shows, etc. I also understand that derms involved in this beta testing will provide them a way of getting their hands on an Aura sooner than later. My point is that these derms are not being compensated for participating in beta testing (and will even be blinded to results) but at beta testing conclusion these derms will receive a commercial version of the Aura at a discount in kind. Essentially VRS' first sales.

 

Bullboard Posts